
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 857 | 884 | 1051 | 1617 | 2901 | 3549 |
Fund Return | -14.28% | -11.55% | 5.12% | 17.38% | 23.74% | 13.51% |
Place in category | 18 | 31 | 67 | 38 | 31 | 8 |
% in Category | 15 | 50 | 78 | 44 | 54 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Small Cap Fund Bonus | 554.91B | -20.12 | 20.26 | 18.95 | ||
Reliance Small Cap Fund Dividend | 554.91B | -20.70 | 19.45 | 19.17 | ||
Reliance Small Cap Fund Growth | 554.91B | -20.12 | 20.26 | 18.95 | ||
Reliance Small Cap Fund Dir Bon | 554.91B | -20.03 | 21.28 | 20.09 | ||
Reliance Small Cap Fund Dir Gr | 554.91B | -20.52 | 20.62 | 20.32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Dividend Payout | 80.81B | -14.99 | 16.77 | 14.45 | ||
Reliance Pharma Fund - Growth | 80.81B | -14.28 | 17.38 | 13.51 | ||
Reliance Pharma Direct Bonus | 80.81B | -14.16 | 18.44 | 14.52 | ||
Reliance Pharma Direct Growth | 80.81B | -14.16 | 18.44 | 14.52 | ||
Reliance Pharma Dir Div Payout | 80.81B | -14.78 | 17.99 | 15.28 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.68 | 1,707.20 | +2.45% | |
Divi's Labs | INE361B01024 | 9.32 | 5,447.30 | +3.58% | |
Lupin | INE326A01037 | 7.73 | 1,974.00 | +2.65% | |
Cipla | INE059A01026 | 5.90 | 1,428.00 | +3.13% | |
Dr Reddy’s Laboratories | INE089A01031 | 5.35 | 1,109.00 | +1.94% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review